Skip to main content

Page of 5
and
  1. Article

    Open Access

    Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma

    Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare highly aggressive subtype of kidney cancer for which the distinct genomic, transcriptomic, and evolutionary relationships between metastatic...

    Jiayu Liang, Guangxi Sun, **uyi Pan, Mengni Zhang, Pengfei Shen, Sha Zhu in Genome Medicine (2023)

  2. Article

    Open Access

    A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma

    Cuproptosis is recently emerging as a hot spot in cancer research. However, its role in pancreatic adenocarcinoma (PAAD) has not yet been clarified. This study aimed to explore the prognostic and therapeutic i...

    Qixian Liu, Ruiyu Li, Huanwen Wu, Zhiyong Liang in BMC Cancer (2023)

  3. Article

    Open Access

    Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

    With the advent of intensive combination regimens, an increasing number of patients with unresectable pancreatic cancer (UPC) have regained the opportunity for surgery. We investigated the clinical benefits an...

    **ang Li, **nyuan Liu, Na Lu, Yiwen Chen, **aochen Zhang, Chengxiang Guo in BMC Cancer (2023)

  4. Article

    Open Access

    Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis

    As a first-line imaging modality, whole-body fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and 18F-FDG PET/magnetic resonance imaging (MRI) had been widel...

    Cici Zhang, Zhishan Liang, Wei Liu, Xuwen Zeng, Yuzhen Mo in BMC Cancer (2023)

  5. Article

    Open Access

    Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study

    Epidermal growth factor receptor (EGFR) amplification refers to the copy number increase of EGFR gene, and is often identified as a “bypass” way of Epidermal growth factor receptor Tyrosine kinase inhibitors (...

    Duanyang Peng, **an Liang, Congying Zhong, Peng Xu, Yanqing He, Yuxi Luo in BMC Cancer (2022)

  6. Article

    Open Access

    Long-term results of postoperative unsuspected small cell lung cancer on real-world data

    In traditional opinion, solid pulmonary nodule suspected lung cancer should be confirmed by pathology before the operation to exclude small cell lung cancer (SCLC), considering SCLC tends to be aggressive and ...

    Juntang Guo, Leilei Shen, Zhipeng Ren, Yang Liu, Chaoyang Liang in BMC Cancer (2022)

  7. Article

    Open Access

    Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia

    Umbilical cord blood transplantation (UCBT) from unrelated donors is one of the successful treatments for acute leukemia in childhood. The most frequent side effect of UCBT is peri-engraftment syndrome (PES), ...

    **n-Yu Li, Li-** Zhan, Dian-Dian Liu, **a-Wei Han, Han Chen, Zheng-Zhou Wu in BMC Cancer (2022)

  8. Article

    Open Access

    Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis

    The study aimed to compare efficacy and safety of various immune checkpoint inhibitors for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC).

    Tian-Tian Gao, Jia-Hui Shan, Yu-**an Yang, Ze-Wei Zhang, Shi-Liang Liu in BMC Cancer (2022)

  9. Article

    Open Access

    Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study

    Single-agent immunotherapy is currently the recommended second-line therapy for patients with advanced non–small cell lung cancer (NSCLC) without targetable mutations; however, the objective response rate (ORR...

    Yongchang Zhang, Lianxi Song, Liang Zeng, Yi **ong, Li Liu, Chunhua Zhou in BMC Cancer (2022)

  10. Article

    Open Access

    Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma

    Distinguishing patients at a greater risk of recurrence is essential for treating locoregional advanced nasopharyngeal carcinoma (NPC). This study aimed to explore the potential of aldo–keto reductase 1C4 (AKR...

    Shan-Shan Guo, Yan-Zhou Chen, Li-Ting Liu, Rong-** Liu, Yu-**g Liang in BMC Cancer (2022)

  11. Article

    Open Access

    Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response

    Recent investigations of the meninges have highlighted the importance of the dura layer in central nervous system immune surveillance beyond a purely structural role. However, our understanding of the meninges...

    Anthony Z. Wang, Jay A. Bowman-Kirigin, Rupen Desai, Liang-I Kang in Genome Medicine (2022)

  12. Article

    Open Access

    Reflecting on the utility of standardized uptake values on 18F-FDG PET in nasopharyngeal carcinoma

    To rethink the clinical significance of standardized uptake values (SUVs) of nasopharyngeal carcinoma (NPC) on 18F-fluorodeoxyglucose (18F-FDG) positron-emission tomography (PET).

    **ufang Qiu, Haixia Wu, Ting Xu, Shihan **e, Ziqing You, Yixin Hu in BMC Cancer (2022)

  13. Article

    Open Access

    Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma

    To evaluate the prognostic value of the apparent diffusion coefficient (ADC) derived from diffusion-weighted magnetic resonance imaging (MRI) and monitor the early treatment response to induction chemotherapy ...

    Li-Ting Liu, Shan-Shan Guo, Hui Li, Chao Lin, Rui Sun, Qiu-Yan Chen in BMC Cancer (2021)

  14. Article

    Open Access

    POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial

    Various randomized trials have demonstrated that postmastectomy radiotherapy (RT) to the chest wall and comprehensive regional nodal areas improves survival in patients with axillary node-positive breast cance...

    Xu-Ran Zhao, Hui Fang, Yu Tang, Zhi-Hui Hu, Hao **g, Lin Liang, Xue-Na Yan in BMC Cancer (2021)

  15. Article

    Open Access

    The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma

    Epstein-Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) present unique molecular signatures, but the tumorigenesis of EBVaGCs and the role EBV plays during this process remain poorly understood.

    Zhang-Hua Chen, Shu-Mei Yan, **-** Chen, Qi Zhang, Shang-**n Liu in Genome Medicine (2021)

  16. Article

    Open Access

    Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study

    Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with a poor prognosis. Given the limited treatment options, prognostic assessment of ACC is increasingly crucial. In this study, we aim to ass...

    Fuxun Zhang, Zhihong Liu, Jiayu Liang, Shengzhuo Liu, Kan Wu, Fan Zhang in BMC Cancer (2021)

  17. Article

    Open Access

    Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial

    Here we evaluated the feasibility, efficacy, tolerability, and treatment-mediated immune modulation of neoadjuvant everolimus plus letrozole versus chemotherapy in treating postmenopausal patients with ER-posi...

    Wei Wu, Jiewen Chen, Heran Deng, Liang **, Zhanghai He, Nanyan Rao, Yan Nie in BMC Cancer (2021)

  18. Article

    Open Access

    Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis

    Various studies investigating the clinical significance of FBXW7 mutation and/or expression have yielded inconclusive results in colorectal cancer (CRC) patients. Therefore, the present meta-analysis summarize...

    Wei Shang, Chuanwang Yan, Ran Liu, Lili Chen, Dongdong Cheng, Liang Hao in BMC Cancer (2021)

  19. Article

    Open Access

    Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study

    This retrospective study aimed to evaluate the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with stereotactic body radiation therapy (SBRT) and to elucidate potential m...

    **a Wang, Zhimin Zeng, **g Cai, Peng Xu, **an Liang, Yuxi Luo, Anwen Liu in BMC Cancer (2021)

  20. Article

    Open Access

    A high level of lncFGD5-AS1 inhibits epithelial-to-Mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer

    Long non-coding RNA (lncRNA) was a vital factor in the progression and initiation of human cancers. This study found a new lncRNA, FGD5-AS1, which can inhibit EMT process, proliferation, and metastasis in vitr...

    Lin Liu, Cheng Zhang, Jizhao Wang, Xu Liu, Hangying Qu, Guangjian Zhang in BMC Cancer (2021)

Page of 5